AgeX Therapeutics, Inc. (AGE)

NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.786
-0.014 (-1.79%)
Jan 27, 2023, 4:00 PM EST - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Net Income
-8.68-10.87-12.15-7.5-6.58-15.49
Depreciation & Amortization
0.131.260.950.540.680.85
Share-Based Compensation
10.911.911.290.340.98
Other Operating Activities
-0.310.88-0.86-2.32-0.735.24
Operating Cash Flow
-7.86-7.82-10.16-8-6.29-8.43
Capital Expenditures
0-0.02-0.64-0.02-0-0.02
Acquisitions
0.42000-00
Change in Investments
0.2500.353.2200
Other Investing Activities
---0.07-1.870.01-0.01
Investing Cash Flow
0.67-0.02-0.361.330.01-0.03
Share Issuance / Repurchase
0.504.56100
Debt Issued / Paid
6.756.121.77000
Other Financing Activities
--0.16--3.287.25
Financing Cash Flow
7.255.966.27613.287.25
Net Cash Flow
0.06-1.88-4.26-0.677.12-1.24
Free Cash Flow
-7.86-7.84-10.8-8.02-6.29-8.45
Free Cash Flow Margin
-5454.86%-2170.91%-625.06%-574.21%-447.72%-507.20%
Free Cash Flow Per Share
-0.21-0.21-0.29-0.23-0.20-0.29
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).